Vimarsana
Biggest News Aggregation in the World

Page 2 - Biocon Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biocon Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biocon Pharma Today - Breaking & Trending Today

Serum Institute to double its investment in Biocon unit to $300 million - Vimarsana News

Serum Institute to double its investment in Biocon unit to $300 million

Serum Institute Life Sciences will now double its investment in Biocon Biologics from $150 million that was announced earlier in 2021 to $300 million.

Serum Institute to invest $300 mn in Biocon's unit, provide access to 100 mn vaccine doses annually - Vimarsana News

Serum Institute to invest $300 mn in Biocon's unit, provide access to 100 mn vaccine doses annually

Serum Institute of Life Sciences has announced to double up its investment in Biocon's unit to $300 million. With this, Biocon's unit will also get access to SILS' 100 million vaccine doses annually

Biocon-Serum deal: Serum to double investment in Biocon's unit to $300 million - Vimarsana News

Biocon-Serum deal: Serum to double investment in Biocon's unit to $300 million

Serum Life Sciences would make an additional equity investment of $150 million through the conversion of the $150 million loan provided to Biocon Pharma Limited.

Serum Life Sciences to make additional $150 million funding in Biocon Biologics - Vimarsana News

Serum Life Sciences to make additional $150 million funding in Biocon Biologics

This investment is in addition to the $ 150 million that SILS had invested in Biocon Biologics in November 2022, resulting in SILS’s aggregate equity investment in BBL amounting to $300 million.

Serum Institute of India invests $150 M more into Biocon Biologics - Vimarsana News

Serum Institute of India invests $150 M more into Biocon Biologics

Serum & Biocon Biologics agree to restructure equity investment